MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (HOLX), a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and treat health ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius™ Digital Diagnostics System with the Genius™ Cervical AI algorithm has received clearance from the ...

Hologic HOLX is a leading name in the cytology space, with its Cytology business, part of its Diagnostics franchise, primarily focusing on screening for cervical cancer. The company has pioneered the ...

BTIG analyst Ryan Zimmerman notes that the U.S. Preventive Services Task Force released a draft recommendation statement on screening for cervical cancer, recommending testing every three years for ...

The FDA approval is immensely beneficial to patients as the 16, 18 and/or 45 strains of the virus are associated with approximately 80% of all invasive cervical cancers worldwide. The Aptima HPV ...

CHICAGO (Reuters) - Medical diagnostics company Hologic Inc said on Monday it would buy Third Wave Technologies Inc for $580 million to expand its range of tests to detect women's health conditions.

Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and ...